US Patent Issued to Regeneron Pharmaceuticals on Oct. 6 for "BCMA chimeric antigen receptors" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,006, issued on Oct. 6, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"BCMA chimeric antigen receptors" was invented by Shannon Grande Contrastano (Auburndale, Mass.) and Emily G. Kuiper (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides improved compositions for adoptive T cell therapies for B cell related conditions."

The patent was filed on Aug. 24, 2021, under Application No. 18/023,232.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=A...